Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel
Kayhan Mehdizadeh, Farangis Ataei, Saman Hosseinkhani
Topics & Concepts
DocetaxelBortezomibProteasome inhibitorApoptosisCancer researchCancer cellPropidium iodideProteasomePharmacologyProgrammed cell deathChemistryBiologyCancerMedicineImmunologyInternal medicineBiochemistryMultiple myelomaCell death mechanisms and regulationUbiquitin and proteasome pathwaysCancer-related Molecular Pathways